Editorial
World J Gastroenterol
31(10):101838.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.101838
Abstract (413)
|
Core Tip (471)
|
Full Article (HTML) (1840)
|
Full Article (PDF)-378K (122)
|
Full Article with Cover (PDF)-633K (114)
|
Full Article (XML)-71K (76)
|
Audio-3309K (20)
|
Peer-Review Report-245K (68)
|
Answering Reviewers-157K (74)
|
Received: 09/28/2024
|
Revised: 01/23/2025
|
Accepted: 02/05/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (2)
|
Total Visits (3937)
|
Similar Articles (151)
|
Timeline of Article Publication (9)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Review
Overcoming antibiotic-resistant Helicobacter pylori infection: Current challenges and emerging approaches

World J Gastroenterol
31(10):102289.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.102289
Abstract (546)
|
Core Tip (452)
|
Full Article (HTML) (9853)
|
Figures (1-1) (444)
|
Tables (1-3) (442)
|
Full Article (PDF)-4025K (417)
|
Full Article with Cover (PDF)-4275K (216)
|
Full Article (XML)-507K (87)
|
Audio-1047K (29)
|
Peer-Review Report-271K (97)
|
Answering Reviewers-120K (105)
|
Received: 10/13/2024
|
Revised: 11/28/2024
|
Accepted: 01/17/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (7)
|
Total Visits (14251)
|
Similar Articles (333)
|
Timeline of Article Publication (14)
|
Authors Evaluation (8)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Minireviews
World J Gastroenterol
31(10):103454.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.103454
Abstract (382)
|
Core Tip (410)
|
Full Article (HTML) (2191)
|
Figures (1-1) (332)
|
Full Article (PDF)-1122K (122)
|
Full Article with Cover (PDF)-1376K (120)
|
Full Article (XML)-113K (76)
|
Audio-412K (17)
|
Peer-Review Report-223K (71)
|
Answering Reviewers-109K (59)
|
Received: 11/20/2024
|
Revised: 12/31/2024
|
Accepted: 02/11/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (5241)
|
Similar Articles (1814)
|
Timeline of Article Publication (10)
|
Authors Evaluation (8)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Case Control Study
Mitochondrial mt12361A>G increased risk of metabolic dysfunction-associated steatotic liver disease among non-diabetes

World J Gastroenterol
31(10):103716.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.103716
Abstract (403)
|
Core Tip (449)
|
Full Article (HTML) (1855)
|
Figures (1-1) (323)
|
Tables (1-6) (309)
|
Full Article (PDF)-876K (106)
|
Full Article with Cover (PDF)-1130K (130)
|
Full Article (XML)-191K (80)
|
Audio-454K (25)
|
Peer-Review Report-229K (63)
|
Answering Reviewers-124K (55)
|
Supplementary Material-657K (66)
|
Received: 11/27/2024
|
Revised: 01/16/2025
|
Accepted: 02/12/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (5486)
|
Similar Articles (53)
|
Timeline of Article Publication (9)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Cohort Study
Endoscopic full-thickness resection: A definitive solution for local complete resection of small rectal neuroendocrine neoplasms

World J Gastroenterol
31(10):100444.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.100444
Abstract (423)
|
Core Tip (476)
|
Full Article (HTML) (1620)
|
Figures (1-4) (337)
|
Tables (1-3) (341)
|
Full Article (PDF)-8140K (178)
|
Full Article with Cover (PDF)-8392K (121)
|
Full Article (XML)-121K (73)
|
Audio-885K (34)
|
Peer-Review Report-197K (80)
|
Answering Reviewers-155K (95)
|
Supplementary Material-123K (65)
|
Received: 08/16/2024
|
Revised: 12/11/2024
|
Accepted: 02/10/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (5992)
|
Similar Articles (18)
|
Timeline of Article Publication (11)
|
Authors Evaluation (7)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Study
World J Gastroenterol
31(10):102393.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.102393
Abstract (413)
|
Core Tip (486)
|
Full Article (HTML) (1618)
|
Figures (1-2) (361)
|
Tables (1-3) (336)
|
Full Article (PDF)-3168K (169)
|
Full Article with Cover (PDF)-3422K (138)
|
Full Article (XML)-97K (77)
|
Audio-586K (23)
|
Peer-Review Report-221K (104)
|
Answering Reviewers-311K (73)
|
Supplementary Material-128K (81)
|
Received: 10/16/2024
|
Revised: 01/04/2025
|
Accepted: 02/08/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (7)
|
Total Visits (5436)
|
Similar Articles (3)
|
Timeline of Article Publication (5)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Basic Study
Circular RNA contributes to gastric cancer by targeting Wnt family member 2B as a competing endogenous RNA

World J Gastroenterol
31(10):99583.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.99583
Abstract (377)
|
Core Tip (423)
|
Full Article (HTML) (1318)
|
Figures (1-6) (320)
|
Full Article (PDF)-10367K (126)
|
Full Article with Cover (PDF)-10622K (129)
|
Full Article (XML)-108K (71)
|
Audio-200K (12)
|
Peer-Review Report-203K (73)
|
Answering Reviewers-316K (109)
|
Received: 10/23/2024
|
Revised: 12/26/2024
|
Accepted: 01/23/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (3698)
|
Similar Articles (1228)
|
Timeline of Article Publication (3)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Platelet activation relieves liver portal hypertension via the lymphatic system though the classical vascular endothelial growth factor receptor 3 signaling pathway

World J Gastroenterol
31(10):100194.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.100194
Abstract (396)
|
Core Tip (386)
|
Full Article (HTML) (1780)
|
Figures (1-8) (387)
|
Full Article (PDF)-42475K (157)
|
Full Article with Cover (PDF)-42729K (139)
|
Full Article (XML)-113K (80)
|
Audio-352K (18)
|
Peer-Review Report-309K (62)
|
Answering Reviewers-116K (65)
|
Supplementary Material-190K (73)
|
Received: 08/09/2024
|
Revised: 12/16/2024
|
Accepted: 01/21/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (4548)
|
Similar Articles (143)
|
Timeline of Article Publication (12)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Lactococcus garvieae aggravates cholestatic liver disease by increasing intestinal permeability and enhancing bile acid reabsorption

World J Gastroenterol
31(10):101014.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.101014
Abstract (379)
|
Core Tip (430)
|
Full Article (HTML) (1669)
|
Figures (1-6) (322)
|
Tables (1-1) (355)
|
Full Article (PDF)-10815K (145)
|
Full Article with Cover (PDF)-11065K (139)
|
Full Article (XML)-143K (72)
|
Audio-400K (16)
|
Peer-Review Report-253K (61)
|
Answering Reviewers-98K (66)
|
Supplementary Material-270K (72)
|
Received: 09/03/2024
|
Revised: 12/19/2024
|
Accepted: 02/05/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (5745)
|
Similar Articles (18)
|
Timeline of Article Publication (5)
|
Authors Evaluation (5)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
SEL1L-mediated endoplasmic reticulum associated degradation inhibition suppresses proliferation and migration in Huh7 hepatocellular carcinoma cells

World J Gastroenterol
31(10):103133.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.103133
Abstract (436)
|
Core Tip (448)
|
Full Article (HTML) (1674)
|
Figures (1-7) (380)
|
Full Article (PDF)-9623K (143)
|
Full Article with Cover (PDF)-9876K (129)
|
Full Article (XML)-121K (69)
|
Audio-824K (16)
|
Peer-Review Report-275K (67)
|
Answering Reviewers-363K (80)
|
Supplementary Material-48K (57)
|
Received: 11/10/2024
|
Revised: 01/04/2025
|
Accepted: 02/05/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (4558)
|
Similar Articles (1793)
|
Timeline of Article Publication (7)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Letter to the Editor
Nab-paclitaxel plus capecitabine as a first-line regimen for advanced biliary tract cancers: Feasible or not feasible?

World J Gastroenterol
31(10):100771.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.100771
Abstract (381)
|
Core Tip (424)
|
Full Article (HTML) (904)
|
Figures (1-1) (348)
|
Tables (1-2) (353)
|
Full Article (PDF)-471K (86)
|
Full Article with Cover (PDF)-728K (68)
|
Full Article (XML)-61K (74)
|
Audio-512K (22)
|
Peer-Review Report-257K (55)
|
Answering Reviewers-156K (64)
|
Received: 08/25/2024
|
Revised: 01/10/2025
|
Accepted: 02/10/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (3387)
|
Similar Articles (25)
|
Timeline of Article Publication (4)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Gastroenterol
31(10):102580.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.102580
Abstract (469)
|
Core Tip (512)
|
Full Article (HTML) (1683)
|
Tables (1-1) (427)
|
Full Article (PDF)-370K (118)
|
Full Article with Cover (PDF)-625K (106)
|
Full Article (XML)-56K (76)
|
Audio-2970K (15)
|
Peer-Review Report-217K (65)
|
Answering Reviewers-149K (69)
|
Received: 10/22/2024
|
Revised: 01/16/2025
|
Accepted: 02/08/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (4178)
|
Similar Articles (170)
|
Timeline of Article Publication (3)
|
Authors Evaluation (4)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Gastroenterol
31(10):102725.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.102725
Abstract (435)
|
Core Tip (443)
|
Full Article (HTML) (3714)
|
Figures (1-1) (342)
|
Full Article (PDF)-1500K (154)
|
Full Article with Cover (PDF)-1754K (129)
|
Full Article (XML)-97K (71)
|
Audio-476K (26)
|
Peer-Review Report-468K (65)
|
Answering Reviewers-1818K (84)
|
Received: 10/27/2024
|
Revised: 01/16/2025
|
Accepted: 01/23/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (2)
|
Total Visits (6251)
|
Similar Articles (274)
|
Timeline of Article Publication (3)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Treatment of intermediate-to-advanced unresectable hepatocellular carcinoma is shifting toward a multidisciplinary strategy that includes multiple modalities as needed

World J Gastroenterol
31(10):103420.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.103420
Abstract (385)
|
Core Tip (418)
|
Full Article (HTML) (1761)
|
Figures (1-1) (305)
|
Tables (1-1) (330)
|
Full Article (PDF)-578K (108)
|
Full Article with Cover (PDF)-834K (122)
|
Full Article (XML)-91K (56)
|
Audio-833K (23)
|
Peer-Review Report-243K (56)
|
Answering Reviewers-100K (54)
|
Received: 11/18/2024
|
Revised: 01/31/2025
|
Accepted: 02/12/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (4352)
|
Similar Articles (1793)
|
Timeline of Article Publication (4)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Gastroenterol
31(10):103973.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.103973
Abstract (416)
|
Core Tip (463)
|
Full Article (HTML) (3935)
|
Full Article (PDF)-406K (249)
|
Full Article with Cover (PDF)-661K (158)
|
Full Article (XML)-95K (82)
|
Audio-989K (25)
|
Peer-Review Report-215K (59)
|
Answering Reviewers-118K (66)
|
Received: 12/05/2024
|
Revised: 01/24/2025
|
Accepted: 02/11/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (2)
|
Total Visits (6194)
|
Similar Articles (3)
|
Timeline of Article Publication (2)
|
Authors Evaluation (4)
|
Article Quality Tracking (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Two treatment methods for hepatocellular carcinoma: Lenvatinib or bevacizumab combined with sintilimab and interventional therapy

World J Gastroenterol
31(10):104429.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.104429
Abstract (408)
|
Core Tip (374)
|
Full Article (HTML) (1229)
|
Tables (1-1) (329)
|
Full Article (PDF)-366K (109)
|
Full Article with Cover (PDF)-621K (143)
|
Full Article (XML)-45K (72)
|
Audio-1658K (21)
|
Peer-Review Report-175K (55)
|
Answering Reviewers-38K (61)
|
Received: 12/19/2024
|
Revised: 01/13/2025
|
Accepted: 01/24/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (3601)
|
Similar Articles (1845)
|
Timeline of Article Publication (3)
|
Authors Evaluation (6)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open